Loading...
Ons wil graag hê dat jy deel word van ons gemeenskap. Sluit aan by ons Discord om met ons en ander lede te skakel!
- Ticker
- BRNS
- Price
- 0.84
- Stock movement down
- -0.03 (-3.32%)
- Company name
- Barinthus Biotherapeutics plc
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology
- Markkapitalisasie
- 34.25M
- Ondernemingswaarde
- -
- Prys/Verkope
- -
- Prys/Boek
- -
- Dividendopbrengs
- -
- Dividendgroei
- -
- Groei jare
- -
- FCF uitbetaling
- -
- Agterlopende P/E
- -
- Volgende P/E
- -
- PEG
- -
- EPS groei
- -
- 1 jaar opbrengs
- -50.23%
- 3 jaar opbrengs
- -41.49%
- 5 jaar opbrengs
- -
- 10 jaar opbrengs
- -
Laaste opgedateer: 2025-08-27
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
DIVIDENDE
BRNS betaal nie dividende nie of geen data is ontvang nie
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
WAARDERING
Waarderingsverhoudings
Loading...
Waarderingsverhoudings gegewens
| Agterlopende P/E | - |
| Prys tot OCF | - |
| Prys tot FCF | - |
| Prys tot EBITDA | - |
| EV tot EBITDA | - |
Waardering (Verkope/Boekwaarde)
Loading...
Waardering (Verkope/Boekwaarde) gegewens
| Prys tot verkope | - |
| Prys tot Boekwaarde | - |
| EV tot verkope | - |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
FINANSIËLE
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
AANDELE INLIGTING
Aandele grafiek
Loading...
Aandele prys data
| Open | 0.92 |
| Daaglikse hoog | 0.93 |
| Daaglikse laag | 0.82 |
| Daaglikse volume | 28K |
| Hoogtepunt van alle tye | 17.00 |
| 1j analiseraaming | 4.50 |
| Beta | -0.72 |
| EPS (TTM) | - |
| Dividend per aandeel | - |
| Ex-dividend datum | - |
| Volgende verdienste datum | 6 Nov 2025 |
Afwaartse potensiaal
Loading...
Afwaartse potensiaal gegewens
| BRNS | S&P500 | |
| Huidige prysdaling vanaf die hoogste punt van alle tye | -95.05% | -3.04% |
| Hoogste prysdaling | -96.15% | -56.47% |
| Datum van hoogste daling | 23 May 2025 | 9 Mar 2009 |
| Gemiddelde daling vanaf hoogtepunt | -72.17% | -11.04% |
| Gemiddelde tyd tot nuwe hoogtepunt | 115 days | 12 days |
| Maksimum tyd tot nuwe hoogtepunt | 1029 days | 1805 days |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
MAATSKAPPY BESONDERHEDE
Markkapitalisasie
34.25M
Markkapitalisasie kategorie
Small-cap
Beskrywing
Barinthus Biotherapeutics plc, a clinical-stage biopharmaceutical company, focuses on developing immunotherapeutic drug candidates for treating auto-immune and inflammatory diseases. Its lead candidate is VTP-1000, which is in Phase 1 clinical trial to restore immune non-responsiveness to gluten in patients with celiac disease. The company is also developing VTP-300, an immunotherapeutic targeting chronic hepatitis B virus infection; VTP-200, a potential non-invasive treatment for persistent high-risk human papillomavirus; VTP-850, an immunotherapeutic candidate for prostate cancer; VTP-600, an immunotherapeutic candidate targeting MAGE-A3 and NY-ESO1 antigens; VTP-500, a prophylactic vaccine candidate to prevent middle east respiratory syndrome; VTP-400, a prophylactic vaccine candidate for shingles; and Vaxzevria, a prophylactic vaccine for the prevention of COVID-19 infection. The company was formerly known as Vaccitech plc and changed its name to Barinthus Biotherapeutics plc in November 2023. Barinthus Biotherapeutics plc was founded in 2016 and is headquartered in Didcot, the United Kingdom.
Werknemers
105
Webwerf
Beleggerverhoudings
-
SEC lêers
CEO
Land
USA
Stad
Aandele tipe
-
CCC status
-
Dividendfrekwensie
-
GEBEURE EN AANBIEDINGS
GebeureAanbiedings
Loading...
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
VERSTAAN DIE BESIGHEID
Loading...
MAATSKAPPY NUUS
Seeking AlphaPersvrystellings
iO Charts is a Seeking Alpha partnerVolgende bladsy